EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer

被引：249

作者：

Horn, Leora ^{[1
]}

Pao, William ^{[1
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 26期

关键词：

GROWTH-FACTOR RECEPTOR; ACTIVATING MUTATIONS; FUSION GENE; ALK KINASE; KRAS MUTATIONS; NEVER SMOKERS; PHASE-III; NPM-ALK; GEFITINIB; IDENTIFICATION;

D O I：

10.1200/JCO.2009.23.6661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4232 / 4235

页数：4

共 50 条

[1] EML4-ALK fusion gene in resected non-small-cell lung cancer
Takahashi, Tsuyoshi
Sonobe, Makoto
Menju, Toshi
Nakayama, Ei
Mino, Nobuya
Iwakiri, Shotaro
Sato, Kiyoshi
Miyahara, Ryo
Okubo, Kenichi
Date, Hiroshi
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S483 - S484
[2] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Soda, Manabu
Choi, Young Lim
Enomoto, Munehiro
Takada, Shuji
Yamashita, Yoshihiro
Ishikawa, Shunpei
Fujiwara, Shin-ichiro
Watanabe, Hideki
Kurashina, Kentaro
Hatanaka, Hisashi
Bando, Masashi
Ohno, Shoji
Ishikawa, Yuichi
Aburatani, Hiroyuki
Niki, Toshiro
Sohara, Yasunori
Sugiyama, Yukihiko
Mano, Hiroyuki
NATURE, 2007, 448 (7153) : 561 - U3
[3] Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4-ALK Fusion Gene
Takahashi, Tsuyoshi
Sonobe, Makoto
Kobayashi, Masashi
Yoshizawa, Akihiko
Menju, Toshi
Nakayama, Ei
Mino, Nobuya
Iwakiri, Shotaro
Sato, Kiyoshi
Miyahara, Ryo
Okubo, Kenichi
Manabe, Toshiaki
Date, Hiroshi
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) : 889 - 897
[4] Epidemiology of EML4-ALK translocations in a small, German non-small-cell lung cancer patient cohort
Schildgen, Verena
Lochl, Vincenza
Luesebrink, Jessica
Brockmann, Michael
Schildgen, Oliver
PERSONALIZED MEDICINE, 2012, 9 (08) : 801 - 803
[5] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, Alice T.
Yeap, Beow Y.
Mino-Kenudson, Mari
Digumarthy, Subba R.
Costa, Daniel B.
Heist, Rebecca S.
Solomon, Benjamin
Stubbs, Hannah
Admane, Sonal
McDermott, Ultan
Settleman, Jeffrey
Kobayashi, Susumu
Mark, Eugene J.
Rodig, Scott J.
Chirieac, Lucian R.
Kwak, Eunice L.
Lynch, Thomas J.
Iafrate, A. John
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4247 - 4253
[6] The biology and treatment of EML4-ALK non-small cell lung cancer
Sasaki, Takaaki
Rodig, Scott J.
Chirieac, Lucian R.
Janne, Pasi A.
EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1773 - 1780
[7] EML4-ALK fusion gene in non-small cell lung cancer
Lei, Yu
Lei, Yan
Shi, Xiang
Wang, Jingjing
ONCOLOGY LETTERS, 2022, 24 (02)
[8] Optic Neuropathy and Blindness Associated With Crizotinib for Non-Small-Cell Lung Cancer With EML4-ALK Translocation
Chun, Stephen G.
Iyengar, Puneeth
Gerber, David E.
Hogan, Robert N.
Timmerman, Robert D.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : E26 - E27
[9] Distinct computed tomography features of non-small-cell lung cancer in a European population with EML4-ALK translocation
Mueller-Lisse U.G.
Zimmermann H.A.
Reiners C.
Reu S.
Reiser M.F.
Huber R.M.
Tufman A.
memo - Magazine of European Medical Oncology, 2017, 10 (2) : 94 - 102
[10] EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.
Karachaliou, Niki
Nilsson, R. Jonas A.
Berenguer, Jordi
Capitan, Ana Gimenez
Schellen, Pepijn
Teixido, Cristina
Kuiper, Justine Leonie
Drees, Esther
Grabowska, Magda
van Keulen, Marte
Tannous, Jihane M.
Heideman, Danielle
Thunnissen, Erik
Dingemans, Anne-Marie C.
Ramirez, Santiago Viteri
Tannous, Bakhos A.
Drozdowskyj, Ana
Smit, Egbert F.
Wurdinger, Thomas
Rosell, Rafael
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →